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Pneumolysin Activates Macrophage Lysosomal Membrane
Permeabilization and Executes Apoptosis by Distinct Mechanisms
without Membrane Pore Formation
Martin A. Bewley,a,b Michael Naughton,a Julie Preston,a Andrea Mitchell,d Ashleigh Holmes,e Helen M. Marriott,a,b Robert C. Read,f
Timothy J. Mitchell,d Moira K. B. Whyte,g David H. Dockrella,b,c
Department of Infection and Immunitya and The Florey Institute for Host-Pathogen Interactions,b University of Sheffield Medical School, Sheffield, United Kingdom;
Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdomc; Institute of Microbiology and Infection, School of Immunity and Infection, University of Birmingham,
Birmingham, United Kingdomd; James Hutton Institute, Dundee, United Kingdome; Academic Unit of Clinical and Experimental Sciences and NIHR Respiratory Biomedical
Research Unit, University of Southampton, Southampton, United Kingdomf; Department of Respiratory Medicine and MRC Centre for Inflammation Research, University
of Edinburgh, Edinburgh, United Kingdomg
M.A.B. and M.N. contributed equally to this article.
ABSTRACT Intracellular killing of Streptococcus pneumoniae is complemented by induction of macrophage apoptosis. Here, we
show that the toxin pneumolysin (PLY) contributes both to lysosomal/phagolysosomal membrane permeabilization (LMP), an
upstream event programing susceptibility to apoptosis, and to apoptosis execution via a mitochondrial pathway, through dis-
tinct mechanisms. PLY is necessary but not sufficient for the maximal induction of LMP and apoptosis. PLY’s ability to induce
both LMP and apoptosis is independent of its ability to form cytolytic pores and requires only the first three domains of PLY.
LMP involves TLR (Toll-like receptor) but not NLRP3/ASC (nucleotide-binding oligomerization domain [Nod]-like receptor
family, pyrin domain-containing protein 3/apoptosis-associated speck-like protein containing a caspase recruitment domain)
signaling and is part of a PLY-dependent but phagocytosis-independent host response that includes the production of cytokines,
including interleukin-1 beta (IL-1). LMP involves progressive and selective permeability to 40-kDa but not to 250-kDa fluores-
cein isothiocyanate (FITC)-labeled dextran, as PLY accumulates in the cytoplasm. In contrast, the PLY-dependent execution of
apoptosis requires phagocytosis and is part of a host response to intracellular bacteria that also includes NO generation. In cells
challenged with PLY-deficient bacteria, reconstitution of LMP using the lysomotrophic detergent LeuLeuOMe favored cell ne-
crosis whereas PLY reconstituted apoptosis. The results suggest that PLY contributes to macrophage activation and cytokine
production but also engages LMP. Following bacterial phagocytosis, PLY triggers apoptosis and prevents macrophage necrosis
as a component of a broad-based antimicrobial strategy. This illustrates how a key virulence factor can become the focus of a
multilayered and coordinated innate response by macrophages, optimizing pathogen clearance and limiting inflammation.
IMPORTANCE Streptococcus pneumoniae, the commonest cause of bacterial pneumonia, expresses the toxin pneumolysin, which
canmake holes in cell surfaces, causing tissue damage. Macrophages, resident immune cells essential for responses to bacteria in
tissues, activate a program of cell suicide called apoptosis, maximizing bacterial clearance and limiting harmful inflammation.
We examined pneumolysin’s role in activating this response. We demonstrate that pneumolysin did not directly form holes in
cells to trigger apoptosis and show that pneumolysin has two distinct roles which require only part of the molecule. Pneumolysin
and other bacterial factors released by bacteria that have not been eaten by macrophages activate macrophages to release inflam-
matory factors but also make the cell compartment containing ingested bacteria leaky. Once inside the cell, pneumolysin ensures
that the bacteria activate macrophage apoptosis, rather than necrosis, enhancing bacterial killing and limiting inflammation.
This dual response to pneumolysin is critical for an effective immune response to S. pneumoniae.
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Streptococcuspneumoniae, thepneumococcus, is a significant causeof morbidity and mortality worldwide, contributing to an esti-
mated 2 million deaths per annum. It is the most frequent cause of
community-acquired pneumonia (1). The toxin pneumolysin (PLY)
is a major virulence factor of S. pneumoniae and is expressed by al-
most all clinical isolates (2–4). PLY is a member of the cholesterol-
dependent cytolysin (CDC) familyofproteins expressedbya rangeof
bacteria (5, 6). Monomeric soluble PLY binds to cholesterol-
containingmembranes and, through adjustment of its fourdomains,
oligomerizes to form a ring-shaped pore (7), which can cause cytol-
ysis inmammalian cells (8). PLY’s role in S. pneumoniae pathogenic-
ity is well documented, with several studies showing that mice in-
fected with PLY-deficient strains of S. pneumoniae display increased
survival time (2), lower bacterial numbers in the nasopharynx (8),
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and decreased bacteremia and less lung damage (9, 10). PLY can also
subvert complement-mediatedopsonization(10–12).However,PLY
also activates immune responses to pneumococci which contribute
to host defense (13). PLY activates T cells (14), induces prostaglandin
production in neutrophils (15), and promotes tumor necrosis factor
alpha (TNF-) production in mononuclear phagocytes (16). Pneu-
molysin is capable of activating inflammasomes, includingmembers
of thenucleotide-bindingoligomerizationdomain (Nod)-like recep-
tor family, pyrin domain-containing protein 3 (NLRP3), and absent
in melanoma 2 (AIM 2), in both dendritic cells and macrophages.
This leads to caspase 1 activation and secretion of interleukin-1 beta
(IL-1), aprocesswhich requires thecytolytic activityof themolecule
and leads to protective immunity to S. pneumoniae (17, 18).
Macrophages are an essential contributor to the host response
to pneumococcal infection, being responsible for the initial detec-
tion of bacteria and subsequent modulation of the inflammatory
response (19). S. pneumoniae-infected macrophages undergo
host-mediated programmed cell death (PCD), which mediates
bactericidal activity in the later stages of the macrophage’s inter-
action when other killing mechanisms are exhausted and which is
a prerequisite for bacterial clearance and resolution of inflamma-
tion (20–22). This form of PCD, which is significantly reduced
during infections using PLY-deficient strains (21, 23), proceeds
along a lysosome-mitochondrion axis involving initial lysosomal/
phagolysosomal membrane permeabilization (LMP), which pre-
cedes the sequential loss of the inner mitochondrial transmem-
brane potential (m), mitochondrial outer membrane
permeabilization (MOMP), caspase 3 activation, and, finally, nu-
clear condensation and fragmentation reminiscent of “classical”
apoptosis (20). Moreover, the cell membrane remains intact until
late in the cell death process and permeabilization is a prominent
feature only when key regulators of the death program are inhib-
ited (23). In this form of PCD, loss of lysosomal acidification
(LLA) is amarker of LMP,which is an apical event in the initiation
of PCD, linking activation of the lysosomal protease cathepsin D
with regulation of cytosolic proteins that control the execution of
the cell death program in themacrophage (20). PLY contributes to
both LLA and cathepsin D activation (20). However, although
PLY contributes to PCD, it is not sufficient, with internalization of
live bacteria being required to unmask the role of PLY (23, 24).
This contrasts with PLY-induced PCD in neurons (25, 26), co-
chlear hair cells (27), lymphocytes (28), and peritoneal macro-
phages (29) in which exogenous PLY alone can induce PCD di-
rectly and implies that host-mediated macrophage PCD in
response to PLY proceeds through an alternative mechanism in
differentiated macrophages.
In this study, we explored how PLY activates host-mediated
macrophage PCD. We show that PLY contributes to PCD induc-
tion through two distinct processes that are independent of its
pore-forming capacity. PLY enhances LMP, contributing to a
phagocytosis-independent process involving Toll-like receptor
(TLR) signaling, but is also required to ensure that, after bacterial
internalization, LMP activates a form of PCD with features of
apoptosis rather than a form of cell death with prominent plasma
membrane permeabilization and cytolysis.
RESULTS
Pneumolysin’s pore-forming ability is not required for host-
mediatedmacrophage apoptosis.Cholesterol-dependent cytoly-
sins (CDCs) exert many of their biological effects through pore
formation (30). To examine the role of pore formation and of
specific domains of PLY in induction of macrophage apoptosis,
we studied a range of S. pneumoniaemutants expressing PLY. The
mutant’s expression of PLY and ability to induce hemolysis were
in keeping with existing knowledge of the protein’s function (see
Fig. S1A and B in the supplemental material). All mutants were
internalized to the same extent (see Fig. S1C).
The ability of eachmutant to induce apoptosiswas examined at
each step of the apoptotic pathway, commencing at LLA, as a
marker of LMP, and progressing through sequential events in the
apoptotic cascade (20). PLY was required for LLA, as the PLY-
deficient strain, D39PLY-Stop (Stop), induced significantly lower
levels of LLA than either the wild-type D39 strain or a strain com-
plemented with full-length (FL) PLY (Fig. 1A and B). However,
6, a strain with no hemolytic activity, induced levels of LLA
similar to those seen with strains D39 and FL as well as to those
seenwith a strain expressing red fluorescent protein (RFP)-tagged
PLY. The same pattern was apparent for each of the subsequent
stages of apoptosis that we examined: loss of m, caspase activa-
tion, and nuclear fragmentation (Fig. 1). To elucidate whether a
particular region of PLYwas required for LLA or apoptosis induc-
tion, macrophages were challenged with either S. pneumoniae
strains expressing the first 3 domains (D1 to D3) or a strain ex-
pressing domain 4 only (D4), which is responsible for PLY’smem-
brane binding (31). Macrophages challenged with S. pneumoniae
expressing D1 to D3 showed levels of each feature similar to those
seen with D39-exposed cells, while exposure to strains expressing
only D4 induced significantly lower levels (Fig. 1). As domains D1
to D3 are not hemolytic (31), these data corroborate the finding
that the pore-forming ability of PLY is not required for apoptosis
induction and suggest that the stimulus for LLA and apoptosis
execution resides in D1 to D3.
Pneumolysin mediates LLA and apoptosis through distinct
pathways. Since PLY directly induces cell death in a range of cell
types and PLY is often a sufficient stimulus for PCD (13), we
addressed whether the presence of PLY was sufficient to induce
macrophage LLA and loss ofm as representative features of the
apoptosis pathway of PCD observed in macrophages after expo-
sure to S. pneumoniae (20). As shown in Fig. S2A and B in the
supplemental material, exogenous PLY, added to reach a concen-
tration of 5 g/ml, failed to induce either LLA or loss of m. In
the presence of bacteria, PLY was required for maximal apoptosis
induction and exogenous PLY reconstituted levels of LLA and
LMP and downstream features of the apoptosis pathway of PCD,
observed in macrophages challenged with S. pneumoniae, when
added to macrophages exposed to the PLY-deficient bacteria
(Fig. 2). This indicates that PLY triggers LLA, LMP, and the apo-
ptotic program only when combined with one or more additional
microbial signals. In line with our prior observations, LLA was
associatedwith LMPduring pneumococcal challenge (Fig. 2A and
B) and we found that PLY alone was also insufficient to activate
cathepsin D (see Fig. S2C), an upstream effector of apoptosis ac-
tivated in macrophage phagolysosomes during S. pneumoniae-
associated PCD (20).
Macrophage PCD in response to S. pneumoniae is dependent
upon internalizationofbacteria (21).Toaddresswhether internaliza-
tion of bacteria is also required for LLA or LMP, macrophages were
treatedwith cytochalasinD,which inhibits actin polymerization (32)
and phagocytosis of opsonized S. pneumoniae (21). Surprisingly, cy-
tochalasin D did not alter LLA or LMP in macrophages challenged
Bewley et al.
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FIG 1 Pneumolysin’s pore-forming ability is not required for macrophage apoptosis. Monocyte-derivedmacrophages (MDM) were either mock infected (MI)
or challenged with wild-type S. pneumoniae (D39), a D39 mutant expressing noncytolytic pneumolysin (6), a pneumolysin-deficient D39 mutant (Stop), or
reconstituted mutants expressing full-length pneumolysin (FL), pneumolysin domains 1 to 3 (D1-3), pneumolysin domain 4 only (D4), or red fluorescent
protein-tagged pneumolysin (RFPPLY). (A to D) At 16 h postchallenge, cells were analyzed for loss of lysosomal acidification (LLA) (A and B) (n 10) or for
loss of the innermitochondrial transmembrane potential (m) (C andD) (n 9). Representative histograms show themock-infected sample in solid gray and
the indicated mutant in white, with the percentage of cells showing loss of the marker indicated (A and C) and summary graphs of all data below (B and D). (E)
At 16 h postchallenge, caspase 3 activity wasmeasured (n 8). (F) At 20 h postchallenge, cells were assessed for nuclear fragmentation (n 9). In all experiments,
**  P  0.01, ***  P  0.001 (one-way ANOVA). All data are expressed as means  standard errors of the means (SEM). Max, maximum; RFU, relative
fluorescence units.
Pneumolysin Domains in Macrophage Apoptosis
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with S. pneumoniae compared to macrophages exposed to bacteria
without cytochalasin D (Fig. 2A and B). PLY also reconstituted LLA
or LMP in macrophages exposed to PLY-deficient bacteria and cy-
tochalasin D (Fig. 2A and B). In contrast, cytochalasin D treatment
inhibitedall stepsafterLMPin thePCDpathway, includingcathepsin
D activation (see Fig. S2C in the supplementalmaterial), loss ofm
(Fig. 2C), caspase 3/caspase 7 activation (Fig. 2D), and nuclear frag-
mentation (Fig. 2E), indicating that all the steps involved in the exe-
cution of apoptosis required bacterial phagocytosis. To confirm that
PCD resembled apoptosis, we also documentedmitochondrial outer
membranepermeabilization (MOMP)andcaspase 9 activation. Fur-
thermore, caspase 1 activity did not contribute to the death pathway
and plasma membrane integrity remained intact until late in PCD
(see Fig. S3).
Recognition of cholesterol-dependent cytolysins and recog-
nition of other microbial factors combine to induce loss of lys-
FIG 2 Pneumolysin mediates LLA and apoptosis through distinct pathways. Monocyte-derived macrophages (MDM) were mock infected (MI) or challenged
with wild-type S. pneumoniae (D39), pneumolysin-deficient D39 (Stop), exogenous pneumolysin (PLY) alone, or Stop with exogenous pneumolysin (PLY),
added at 0.5, 1, or 5 g/ml (increasing doses are indicated a triangle) (A and C) or 5 g/ml (all other panels) in the presence () or absence (-) of cytochalasin
D (CD). At 16 h postchallenge, cells were assessed for loss of lysosomal acidification (LLA) (n  4) (A), fractionated and the cytosolic fractions blotted for
cathepsin B (Cat B), actin, or lysosome-associated membrane protein 1 (LAMP-1) (a representative blot from three independent experiments is shown, with
densitometry data below the blot showing fold change in Cat B levels relative to MI cell levels) (n 3) (B), assessed for loss of inner mitochondrial transmem-
brane potential (m) (n 4) (C), or assessed for caspase 3 activity (n 4) (D), or cells were assessed for nuclear fragmentation at 20 h postchallenge (n 5)
(E). In all experiments, *  P  0.05, **  P  0.01, ***  P  0.001 (one-way or two-way ANOVA for comparisons within or between CD-negative and
CD-positive [-CD andCD] groups, respectively; data are expressed as means SEM). ns, not significant.
Bewley et al.
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osomal acidification. As the response to PLY that led to LLA and
LMP required additional stimuli from whole bacteria but did not
require phagocytosis, we tested whether 2 cell surface pattern rec-
ognition receptors (PRRs) potentially contributing to the host re-
sponse to S. pneumoniae in macrophages contributed to LLA/
LMP (33). Toll-like receptor 2 (TLR2) is known to play a role in
the early inflammatory response to S. pneumoniae (34), and, al-
though TLR4’s roles are debated, TLR4 appears to contribute to
PLY recognition in macrophages (35) and has been implicated in
apoptosis induction (29). To maximize the extracellular signal,
these experimentswere also performed in the presence of cytocha-
lasin D. Although blockade of TLR2 or TLR4 abrogated lipopoly-
saccharide (LPS)- and lipotochoic acid (LTA)-mediated cytokine
production (seemethods), blockade of either TLR2 or TLR4 alone
did not prevent LLA in D39-challenged cells. However, the com-
bination of the two partially inhibited LLA (Fig. 3A) to an extent
that varied with the donor (Fig. 3B). Bone marrow-derived mac-
rophages (BMDM) lacking the MyD88 adaptor protein that reg-
ulates one of theTLR signaling pathways and a pathway utilized by
both TLR2 and TLR4 also demonstrated a reduction in LLA or
LMP (Fig. 3C and D), while those lacking TLR2 or TLR4 individ-
ually did not. This suggested that signaling through both TLR2
andTLR4, and potentially other PRRs, stimulated LLAor LMP. In
keeping with the redundancy associated with TLR responses to
pneumococci, only MyD88/ BMDM had a reduction in early
bacterial killing (Fig. 3E). To assess if there was a contribution to
LLA from the intracellular PRR nuclear oligomerization domain
protein 2 (Nod2), a known sensor of internalized S. pneumoniae
peptidoglycan (36), which may be engaged by microbial factors
internalized through pinocytosis or other pathways not inhibited
by cytochalasin D, cells were incubated with agonists of Nod 1
and/orNod 2.However, these failed to induce LLA (see Fig. S4A in
the supplemental material).
To assess if LLA was strain or species specific, we assessed LLA
in cells challengedwith clinical strains of serotype 1 S. pneumoniae
expressing hemolytic (strain ST227) (37) or nonhemolytic (strain
ST306) PLY (38) or in cells challenged with Streptococcus mitis,
which expresses a cytolysin related to PLY, mitilysin (39). These
strains all induced LLA and downstream features of PCD at levels
comparable to those seen with D39 (see Fig. S4B to F in the sup-
FIG 3 Toll-like receptor 2 (TLR2) signaling and TLR4 signaling combine to induce loss of lysosomal acidification. (A and B) Monocyte-derived macrophages
(MDM) were challenged in the absence (-) or presence () of S. pneumoniaeD39 (Spn), cytochalasin D (CD), a TLR4 antagonist (LPSRS), or a TLR2-blocking
antibody (Anti-TLR2). At 16 h postchallenge, cells were analyzed for loss of lysosomal acidification (LLA) by flow cytometry (n 6). * P 0.05, ** P 0.01
(one-way ANOVA). (B) The percentages of reduction in LLA after D39 challenge for individual donors, comparing untreated cells and those treated with both
anti-TLR2 and LPSRS in the absence of CD. (C to E) Bonemarrow-derivedmacrophages (BMDM) fromwild-type (WT) or Toll-like receptor 2 (TLR2)-, TLR4-,
or myeloid differentiation factor 88 (MyD88)-deficient mice were challenged with strain D39. At 16 h postchallenge, cells were analyzed for loss of lysosomal
acidification (LLA) (C) and lysosomal membrane permeabilization, as characterized by cathepsin B (Cat B) translocation to the cytosol (D). (E) At 8 h
postchallenge, early bacterial killing was determined by a gentamicin protection assay. In all experiments, n  4. *  P  0.05 (one-way ANOVA). Data are
expressed as means SEM.
Pneumolysin Domains in Macrophage Apoptosis
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plemental material). Thus, a conserved response to PLY and re-
lated cytolysins, acting in concert with one or more additional
microbial factors, induces LLA in a phagocytosis-independent
fashion that also requires PRR activation.
Cytoplasmic translocationofpneumolysin is associatedwith
a progressive increase in lysosomal membrane permeabiliza-
tion. The requirement for intracellular bacteria for the execution
phase of macrophage apoptosis implicates intracellular microbial
factors, but we know little concerning the extent of LMP and its
relationship to the cellular localization of PLY after the initial traf-
ficking of bacteria into the phagolysosome (40).Macrophages that
have internalized pneumococci exhibit significant LLA from 10 h
postinfection and show evidence of LMP as determined by trans-
location of lysosomal proteases into the cytoplasm (20). However,
lysosomal integrity could theoretically be compromised earlier to
a more modest extent, allowing efflux of small peptides before
LLA and cathepsin release can be detected. To determine more
accurately the kinetics and extent of lysosomal and phagolyso-
somal permeabilization, the translocation of fluorescein isothio-
cyanate (FITC)-dextranmolecules of various sizes, represented by
the replacement of the normal punctate staining pattern by a
mixed punctate/diffuse or diffuse pattern (Fig. 4A), was mea-
sured. There was progressive translocation of 10-kDa FITC-
dextran molecules into the cytosol, with the translocation visible
6 h after bacterial challenge (Fig. 4B). The redistribution of the
40-kDa FITC-dextran molecules occurred by the 10-h time point
(Fig. 4C). In the cases of both the 10-kDa and the 40-kDa mole-
cules, translocation predominantly resulted in a mixture of both
diffuse staining and punctate staining, indicative of partial lyso-
somal/phagolysosomal efflux. In contrast, the 250-kDa FITC-
dextran remained in the lysosomal/phagolysosomal compart-
ment at all time points (Fig. 4C).
In line with our observations with LLA, treatment of macro-
phages with cytochalasin D had little effect on efflux of 10-kDa or
40-kDa molecules (Fig. 4B and C). As documented with LLA,
challenge with PLY-deficient bacteria partially reduced lysosomal
leakage of 10-kDa and 40-kDa FITC-dextran, suggesting that PLY,
along with additional microbial factors, contributed to LMP.
These data corroborate our prior observations that LLA is a
marker of LMP (20). They also indicate that LMP is selective and
that permeability to medium-sized particles increases progres-
sively with time; permeability to small-sized molecules precedes
LLA or permeability for medium-sized molecules, while lyso-
somes/phagolysosomes remain impermeable to larger particles.
They also confirm that LMP for small-sized and medium-sized
particles is not dependent on phagocytosis.
Wenext investigated the kinetics of PLY localization in relation
to LMP, utilizing a mutant expressing full-length PLY with a red-
fluorescent protein (RFP) label (RFP-PLY). At 4 h after exposure,
red fluorescence could be seen in a punctate distribution which
colocalized with the lysosomal marker BODIPY-pepstatin A
(Fig. 5A). At 8 h postchallenge, the punctate distribution was still
in evidence, but cells also showed a more diffuse red background
staining, indicating that RFP-PLYwas translocating to the cytosol.
At 20 h postchallenge, virtually all red fluorescence was diffuse
(Fig. 5A). Subcellular fractionation andWestern blotting corrob-
orated these findings, with evidence of significant cytosolic trans-
location of RFP-PLY by 10 h (Fig. 5B), suggesting that PLY trans-
location kinetics matched those of LMP for medium-sized
particles.
NLRP3 and ASC do not contribute to host-mediatedmacro-
phage apoptosis. PLY’s translocation from the phagolysosome
could activate a cytosolic pattern recognition receptor to stimulate
the apoptosis pathway. PLY has been shown to activate both the
cytosolic NLRP3 inflammasome (17) and the AIM 2 inflam-
masome, both of which recruit apoptosis-associated speck-like
protein containing a caspase recruitment domain (ASC) (18).
However, upon challenge with S. pneumoniae, murine NLRP3/
and ASC/ BMDM displayed percentages of cells with LLA (see
Fig. S5A in the supplemental material), loss ofm (see Fig. S5B),
and morphological nuclear features of apoptosis (see Fig. S5C)
similar to those seen with control BMDM, suggesting that the
pathways responsible for LLA or the downstream execution phase
of apoptosis do not involve the NLRP3 or other ASC-containing
inflammasomes. However, LLA,m, and nuclear fragmentation
were significantly reduced when cells were challenged with the
PLY-deficient Stop strain (Fig. 4). Caspase 1, which is activated via
the inflammasome, also played no role in macrophage apoptosis
in a murine model of lung infection (see Fig. S5D).
Pneumolysin has distinct consequences for the macrophage
innate immune response that differ with respect to their depen-
denceonphagocytosis.Wenext examinedwhether phagocytosis-
independent and phagocytosis-dependent phases of the apoptosis
response mapped to particular aspects of the macrophage’s PLY-
mediated innate immune response to S. pneumoniae and the rela-
tionship of these immune responses to phagocytosis. As shown in
Fig. S6A to D in the supplemental material, production of several
cytokines was enhanced at later time points by PLY but was not
phagocytosis dependent. This was particularly true for IL-1 and
IL-6, with a similar trend seen for IL-8. In contrast, although we
found little PLY dependence or influence on phagocytosis or pro-
duction of reactive oxygen species (ROS) (see Fig. S6E and F),
nitric oxide (NO) production was dependent both on PLY and on
phagocytosis (see Fig. S6G). This positioned the phagocytosis-
independent PLY response that contributed to LMP alongside ef-
fector functions associated with macrophage activation and cyto-
kine release, but, in contrast, the phagocytosis-dependent PLY
responses associated with apoptosis induction occurred in the
context of macrophages that were activating delayed antimicro-
bial responses, including NO generation.
Intracellular pneumolysin is necessary for optimal engage-
ment of macrophage apoptosis. PLY contributed to LMP inde-
pendently of phagocytosis. In contrast, the execution phase of
macrophage apoptosis required phagocytosis of bacteria, suggest-
ing a role for intracellular microbial factors. Since PLY translo-
cated to the cytosol, we addressed whether intracellular PLY was
also required to execute apoptosis or was required solely to induce
LMP.We reconstituted comparable levels of LMP inmacrophages
containing the PLY-deficient strain and determined whether ap-
optosis occurred to an extent similar to that observed with wild-
type bacteria. The lysomotrophic detergent L-Leucyl-L-leucine
methyl ester (LeuLeuOMe) is a dipeptide which, in lysosomes, is
converted by the lysosomal enzyme dipeptidyl peptidase into a
detergent-like compound which induces LMP (41, 42). The dose
of LeuLeuOMewas selected as the dose that provided levels of LLA
and kinetics comparable to those observed following pneumococ-
cal challenge (see Fig. S7A in the supplemental material). It was
also confirmed that it reconstituted LLA and LMP in cells chal-
lenged with Stop to an extent comparable to that observed in
D39-exposed cells (see Fig. S7B and C). The lysomotrophic deter-
Bewley et al.
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gent did not induce significant apoptosis in the absence of bacteria
but enhanced apoptosis following phagocytosis of PLY-deficient
bacteria, though not to the extent seen with D39 bacteria (see
Fig. 6A; see also Fig. S8A). In contrast, addition of PLY to cells
exposed to the lysomotrophic detergent in the presence of Stop
increased levels of apoptosis over those seen in the absence of PLY
(see Fig. 6A; see also Fig. S8A), whereas PLY had no additional
effect on LMP (see Fig. S7C). This that suggested PLY contributed
to induction of apoptosis in this system downstream of its induc-
tion of LMP.
To establish the fate of cells in the absence of PLY-induced
stimulus for apoptosis induction, we examined rates of overall cell
FIG 4 Macrophages exposed to S. pneumoniae develop a progressive increase in lysosomal membrane permeabilization. (A to C) Monocyte-derived macro-
phages (MDM) were preloaded with 5 mg/ml of FITC-dextran molecules of the designated molecular mass and challenged with S. pneumoniae (D39) or
pneumolysin-deficient (Stop) S. pneumoniae orwithD39 in the presence of cytochalasinD (D39CD). At the designated time postchallenge, cells were fixed and
analyzed by fluorescencemicroscopy and the percentages of cells showingmixed punctate/diffuse or diffuse stainingwere determined. (A) Representative images
of cells showing completely punctate FITC-dextran localization,mixed punctate/diffuse staining, or completely diffuse staining, taken froma strainD39-exposed
population at 10 hpostchallenge. (B andC) Localization of 10-kDa (B) and 40- or 250-kDa (C) FITC-dextran (n 4). *P 0.05 for 10-kDaD39 versus 10-kDa
D39CD; ^ ^ ^ P 0.001 for 10-kDa D39 versus 10-kDa Stop; P 0.01 for 40-kDa D39 versus 40-kDa Stop (two-way ANOVA). Data are expressed
as means SEM.
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death using lactate dehydrogenase (LDH) release as a marker of
cell membrane permeabilization. When we examined LDH re-
lease in the same experiments inwhichwe reconstituted LMPwith
lysomotrophic detergents, we observed that the combination of
LMP and phagocytosed intracellular bacteria in the absence of
PLY resulted in increased levels of LDH and presumably nonapo-
ptotic cell death (Fig. 6B). The enhanced LDH release in the ab-
sence of PLY occurred irrespective of the presence or absence of
LeuLeuOMe treatment and was not modified by the necroptosis
inhibitor necrostatin. There was also no evidence of increased
receptor-interacting serine/threonine protein kinase 1 (RIP1) or
RIP3 levels indicative of necroptosis (43, 44) (see Fig. S8B andC in
the supplementalmaterial), suggesting that, in the absence of PLY,
the macrophages died by toxin-induced cytolysis rather than
through active engagement of a programof necroptosis. Similarly,
we found higher rates of LDH release when macrophages were
exposed to bacteria that expressed only D4 and therefore did not
engage apoptosis as effectively, while bacteria expressing D1 toD3
or 6 bacteria induced levels comparable to those seen with wild-
type bacteria (see Fig. S8C andD). This emphasizes the role of PLY
in ensuring that apoptotic cell death is executed in preference to
other forms of PCD during exposure to S. pneumoniae.
DISCUSSION
Macrophage PCD during S. pneumoniae infection is a host-
mediated response which is essential for the later stages of bacte-
rial killing and pulmonary clearance of bacteria (22, 45). LLA and
LMP are an apical part of the PCD engaged in macrophages fol-
lowing ingestion of S. pneumoniae. Here we show that PLY con-
tributes to both LMP and the subsequent execution of PCD
through distinct mechanisms. These act in concert to trigger the
apoptotic demise of the macrophage. We show that PLY’s contri-
FIG 5 Pneumolysin progressively translocates from phagolysosomes to the cytosol following challenge with live bacteria. (A) Monocyte-derived macrophages
(MDM) were challenged with S. pneumoniae (D39) expressing RFP-tagged pneumolysin (RFP-PLY). At the designated time postchallenge, cells were stained
with BODIPY-pepstatin A to visualize lysosomes. Cells were visualized by fluorescence microscopy. Red, PLY; green, lysosomes; yellow, merged. Images are
representative of the results of three independent experiments. (B) A Western blot of cytosolic and membrane fractions from D39-exposed MDMs at the
designated time points postchallenge probed with anti-pneumolysin (PLY). Actin and lysosome-associatedmembrane protein 1 (LAMP-1) were used as loading
controls. The blots are representative of the results of three independent experiments.
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bution to apoptosis does not involve PLY pore formation but
requires phagocytosis-independent PRR-generated signals, which
prime LMP and also complementation of LMP-derived signals to
ensure execution of apoptosis.
PLY forms pores in cholesterol-containing membranes as a
major mechanism underpinning its biological activity (13, 46).
Neurons, microglia, and dendritic cells appear sensitive to low
concentrations of PLY, and pore formation triggers PCD (25, 47),
while fibroblasts and alveolar epithelial cells are less susceptible in
vitro (48, 49). PLY pore formation triggers LMP in dendritic cells
(17). PLY-induced pores also contribute to lymphocyte apoptosis
(50), while exogenous PLY is a sufficient stimulus to induce apo-
ptosis for relatively undifferentiated phenotypes of murine mac-
rophages (29). We found no evidence that pore-forming activity
was required for LMP or apoptosis in differentiatedmacrophages.
Compositional differences in the plasma membrane and altered
levels of PLY inactivators such as reactive oxygen species (ROS)
result in various levels of susceptibility of cell membranes to PLY-
induced pores and are potential contributors to the relative levels
of resistance of differentiatedmacrophages to PLY pore-mediated
effects (51).
PLY played two distinct roles in the induction of PCD. The first
was phagocytosis independent and resulted in LMP.This response
was potentially extracellular or could have involved PLY or other
LMP-triggering ligands entering the cell through pinocytosis or
other actin-independentmechanisms. LMPwas stimulated under
conditions similar to those associated with the production of sev-
eral cytokines, including IL-1. This observation suggested that
PRR, involved in initial macrophage activation and priming of
host defense by S. pneumoniae, could be involved in LMP induc-
tion (29, 34, 35, 52), and we confirmed potential roles for MyD88
and combined TLR2 and TLR4 signaling in generating LMP.
TLR4 has been suggested to contribute to recognition of PLY in
peritoneal macrophages, leading to cytokine production (35).
However, the involvement of TLR4 in PLY recognition has been
debated. Its relative importance in PLY recognitionmay vary with
cell type, and different PLY-activated signaling pathwaysmay vary
in their requirements for TLR4 recognition. For example, while
NF-B signaling in macrophages in response to PLY was TLR4
dependent (35), nuclear factor of activated T cells (NFAT) (53)
and p38 mitogen-activated protein kinase (MAPK) signaling in
epithelial cells was TLR4 independent (54). Our results are con-
sistent with prior findings linking TLR4-mediated PLY responses
to induction ofmurinemacrophage apoptosis (25, 29) but suggest
that it is the integration of signals frommultiple PRRs that gener-
ates LMP for differentiated human macrophages, although the
relative contributions of TLR differed between donors. This may
be representative of macrophage heterogeneity in levels of TLR
expression, which occurs as macrophages differentiate and which
is thought to add diversity to the immune response and may have
differed among donors (55). The region of the toxin responsible
for this interaction lies within domains 1 to 3 of PLY. The fact that
a range of clinical strains and the related oral commensal S. mitis
all induced LMP suggests that the recognition of the cytolysin and
LMP induction are conserved and not restricted to just S. pneu-
moniae. The association of macrophage activation for cytokine
release with LMP fits with observations that LMP facilitates in-
flammasome activation and optimal release of IL-1 (17). How-
ever, there was a role for TLR activation in priming LMP and early
bacterial killing in the differentiated macrophage, while LMP did
not require PLY pores. Therefore, TLR activation emerges as a
mechanism of LMP that functions as an alternative to the direct
induction by cytolysin-induced pore formation and appears to be
the preferred mechanism operating in differentiated macro-
phages. These findings are most consistent with models where
both initial TLR signals and subsequent NLR signals combine to
optimize release of IL-1 and potentially other cytokines as well as
mediating bacterial killing cascades (56, 57). Host-mediated LMP
would enhance this response.
The specific signaling that led to LMP remains poorly defined.
Phagocytosis-linked changes in kinase signaling or lipid compo-
sition are inconsistent with the lack of effect of cytochalasin D
treatment (58). LMP precedes activation of caspase and other
apoptosis-associated proteases that activate LMP in other settings
in this formof PCD (20). Themost plausible stimuli would appear
to be those arising from PRR activation: mitogen-activated pro-
tein kinase (MAPK) signaling, enzymes regulating lipid mem-
brane composition, such as phospholipase A2, and ROS-induced
FIG 6 Pneumolysin contributes to maximal engagement of apoptosis. Monocyte-derived macrophages (MDM) were mock infected (MI; white bar) or
challenged with either wild-type S. pneumoniae (D39; black bar) or pneumolysin-deficient D39 (Stop; gray bar). Cells were challenged in the presence () or
absence (-) of the lysomotrophic detergent LeuLeuOMe, cytochalasin D (CD), or exogenous pneumolysin (5 g/ml). At 20 h postchallenge, cells were assessed
for nuclear fragmentation (n 6) (A) or for necrosis (n 5) (B) by measuring LDH release. * P 0.05, ** P 0.01, *** P 0.001 (one-way ANOVA).
All data are expressed as means SEM.
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peroxidation of lipid membranes (33, 58, 59). To our knowledge,
this is the first reported instance of a toxin recognition system
triggering LMP to engage a host response. In contrast, toxins per-
meabilizing endosomes, as exemplified by diphtheria toxin, are
well described (60). Peptides derived from PLY and potentially
other microbial factors could translocate to the cytosol early after
bacterial phagocytosis and interact with host proteins, enhancing
cytokine release and providing a feedback loop to allow LMP for
larger molecules, including PLY. Our data, however, exclude a
role for the intracellular Nod2, NALP3, or other ASC-containing
pneumococcal recognition systems in LMP or apoptosis induc-
tion.
Although PLY and other pore-forming bacterial toxins (e.g.,
listeriolysin O, streptolysin O, and -hemolysin) activate the
NLRP3 inflammasome (61–64), which activates caspase 1 (17),
pneumococci limit caspase 1 activation in macrophages through
induction of chitinase 3-like protein 1 (65). Pneumococci did not
induce caspase 1-induced pyroptosis in less-differentiated human
monocytes/macrophages under conditions where several Gram-
negative bacteria were shown to do so (66). We also confirmed
that alveolar macrophage PCD is unaltered in caspase 1/ mu-
rine alveolar macrophages following pneumococcal infection,
confirming the PCD is not caspase 1 dependent. Progressive LMP,
however, allows release of lysosomal proteases that prime apopto-
sis (58). We have previously shown cathepsin D activates MOMP,
caspase 3 activation, and nuclear fragmentation in macrophages,
all characteristics of apoptosis, during pneumococcal infection
(20) and once again confirm here that the PCD resembles apopto-
sis. Cathepsin D also upregulates antioxidants, limiting lysosomal
membrane peroxidation and the more extensive LMP associated
with necrosis (20).
PLY contributes to LMP, but a functional requirement for
LMP in apoptosis induction in macrophages phagocytosing
S. pneumoniae has not previously been demonstrated. Like PLY,
LMP is necessary but also not sufficient for induction of apoptosis.
The extent of LMPdetermines the type of PCD (67, 68), and in our
model, LMP is selective, allowing sensitization to apoptosis (58).
The second role for PLY appears to be performed in the context of
bacterial internalization andLMP,where it ensures engagement of
apoptosis. We have shown previously that cathepsin D activation
and induction of apoptosis represents a core component of the
antimicrobial host defense of macrophages (20). This can be
viewed as fitting broadly with PLY’s intracellular role as a stimulus
for the induction of intracellular antimicrobial strategies, which
we show also includes production of NO. Significantly, PLY con-
tributes to the execution phase of apoptosis downstream of LMP
and stimulates apoptosis in contrast to necrosis following induc-
tion of LMPwith a lysomotrophic detergent. A number of studies
illustrated how phagolysosomal cargo helps define the organelle’s
interaction with other endosomes and ultimately, therefore, with
the proteins it contains and how these are activated (69–71). Ca-
thepsin D activation is critical in initiating the apoptotic cascade
post-LMP (20, 72), and we now show that optimal activation of
cathepsin D requires both phagocytosis of bacteria and PLY. PLY
could influence the trafficking of lysosomes to the phagosome
containing pneumococci or influence the resulting activation of
cathepsin D to ensure induction of apoptosis and prevent alterna-
tive nonapoptotic PCD. Induction of apoptosis may also be
viewed as a strategy that downregulates the inflammatory re-
sponse, since LMPwould otherwise allow ongoing inflammasome
activation if the cell remained viable.
Our data therefore suggest a novel model in which PLY, acting
in conjunction with other bacterial factors, first induces LMP by a
mechanism independent of phagocytosis but involving PRR in
activated cytokine-producingmacrophages (see Fig. S9 in the sup-
plemental material). This provides a novel host-mediated mech-
anism of LMP in response to a microorganism. The second stage
of the host response to PLY ensures that the death process exe-
cuted in response to LMP in the presence of intracellular bacteria
is apoptosis, which requires cathepsin D activation (20). These
results extend our understanding of the multifaceted roles of PLY
as a focal point of the innate immune response to pneumococci
that fine-tunes the host-pathogen interaction to ensure optimiza-
tion ofmicrobial killing and limitation of inflammation. Since this
response is conserved among a range of PLY-related toxins and
potentially involves an overlapping range of PRRs, it is likely to
extend to many other microbial factors. Microbial clearance by
tissue macrophages, such as the alveolar macrophage, is a critical
bottleneck in innate host defense and represents a tipping point
for the escalation of inflammatory responses (22). Models such as
this can provide a rational basis for approaches that refocus the
innate response at crucial tipping points and can enable us to
develop host-focused approaches to treatment of common bacte-
rial infections. These results suggest that the combination of the
use of lysomotrophic agents, with the potential to selectively per-
meabilize the phagolysosome, and engagement of select signaling
pathways downstream of this could have utility as part of this
strategy.
MATERIALS AND METHODS
Bacteria. Serotype 2 (D39 strain; NCTC 7466), mutant strains (D396
[6] and D39-PLYSTOP [Stop]), and serotype 1 clinical isolates ST227
(strain INV104B isolated from a patient with invasive pneumococcal dis-
ease [37]) and ST306 (strain 03-2038 isolated from a patient with empy-
ema from the Scottish Haemophilus, Legionella, Meningococcus and
Pneumococcus Reference Laboratory [39]) of S. pneumoniae were grown
as previously described, as was S. mitis (strain R751) (21). Mutant strains
pAHS3 (expressing wild-type [WT] full-length [FL] pneumolysin),
pAHS1 (expressing domains 1 to 3 [D1 to D3]), pAHS2 (expressing do-
main 4 [D4]), and pAHS6 (expressing WT RFP-tagged pneumolysin
[RFPPLY]) (see Text S1 in the supplemental material for details of con-
struction) were grown similarly but in the presence of 1 g/ml erythro-
mycin to maintain the plasmid. Prior to infection with S. pneumoniae,
thawed aliquots were opsonized in RPMI medium (Sigma-Aldrich) con-
taining 10% (vol/vol) anti-pneumococcal immune serum (21). Bacterial
numbers were assessed by the surface viable count method after inocula-
tion of bacteria on blood agar. All strains were verified by the optochin
disc test and by Western blot analysis for PLY.
Hemolytic assay. Hemolytic activity of bacterial strains was assessed
by analyzing hemoglobin release from defibrinated sheep blood (TCS
Biosciences), as previously described (50).
Cells and infection. Human monocyte-derived macrophages
(MDMs) were isolated from whole blood donated by healthy volunteers
as previously described, withwritten informed consent as approved by the
South Sheffield Regional Ethics Committee (21). Murine bone marrow-
derived macrophages from C57BL/6, NALP3/, ASC/, TLR2/,
TLR4/, or MyD88/ mice were isolated and cultured as previously
described (20). Cells were incubated with opsonized pneumococci at a
multiplicity of infection of 10 or mock infected as previously described
(21). Infections involving strains pAHS1, pAHS2, pAHS3, and pAHS6
took place in the presence of 1 g/ml erythromycin. All bacterial strains
were internalized equally (see Fig. S1 in the supplemental material). In
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some experiments, macrophages were treated with 2 g/ml cytochalasin
D (Sigma) to inhibit bacterial internalization. In some experiments, cells
were exposed to TLR2 blocking antibody (Ab) (clone TL2.1; eBioscience)
(1:500) after preblocking for 30 min with 100 g/ml IgG1 (Sigma) or the
TLR4 antagonist lipopolysaccharide (LPS) from the photosynthetic bac-
terium Rhodobacter sphaeroides (Ultrapure LPS-RS) (InvivoGen) at 5g/
ml. The efficacy of blockingTLR2orTLR4was tested by showing 96%and
97% reductions in TNF-production in cells stimulated with 1 g/ml
lipoteichoic acid (LTA) and 10 ng/ml LPS, respectively. All reagents were
added for 30 min prior to challenge with bacteria. In some experiments,
macrophages were exposed to exogenous pneumolysin provided by T.
Mitchell. Exogenous PLY contained0.6 endotoxin units perg protein.
Bacterial internalization. Assessment of intracellular killing was car-
ried out at designated times using a gentamicin protection assay as previ-
ously described (23).
Analysis of loss of lysosomal acidification.Todetect loss of lysosomal
acidification, cells were stained with 5 Mof the azurophilic dye acridine
orange (Sigma-Aldrich) (20) before being analyzed by flow cytometry.
Lysosomal staining. Macrophages were loaded with 1 M pepstatin
A-BODIPY FL conjugate (Invitrogen) in complete media, for 2 h at 37°C,
before being washed in phosphate-buffered saline (PBS) and left over-
night. Cells were imaged using a 40 objective on a fluorescence micro-
scope (Leica DMI4000B) at an excitation value of 476 nm and emission
values of 500 to 600 nm.
Analysis of lysosomal leak. Lysosomal rupture was assessed using
FITC-dextran molecules (Sigma) (10-, 40-, and 250-kDa molecular
mass). In brief, cells were incubated with 5 mg/ml FITC-dextran mole-
cules for 2 h at 37°C. The cells were washed and chased with culture
medium for 3 h (to allow colocalizationwith lysosomes [73]) before being
challenged with bacteria in the normal manner. At the designated time
postinfection, cells were visualized using a 100 objective and a confocal
microscope (Zeiss LSM510 NLO Inverted), and the percentage of cells
with diffuse staining was recorded (73).
Permeabilization of lysosomes. Permeabilization of macrophage ly-
sosomes was achieved using the lysomotrophic detergent L-leucyl-L-
leucine methyl ester (LeuLeuOMe) (Bachem). Macrophages were incu-
bated with 1 mg/ml of LeuLeuoMe to induce permeabilization (66). In
Stop-challenged macrophages, to ensure that permeabilization occurred
at approximately the same time as in cells challenged with wild-type bac-
teria, LeuLeuOMe was added 6 h postchallenge.
SDS-PAGE andWestern immunoblotting.Cytosolic andmembrane
fractions were isolated using digitonin and were subjected to Western
blotting as previously described (20). Blots were blocked and incubated
overnight at 4°Cwith antibodies against PLY (rabbitmonoclonal; Abcam)
(1:1,000), lysosome-associated membrane protein 1 (LAMP-1) (mouse
monoclonal; BD Biosciences) (1:1,000), cathepsin B (rabbit polyclonal;
Abcam) (1:1,000), cytochrome c (mouse monoclonal; BD Pharmingen)
(1:1,000), RIP1 (rabbit polyclonal; Abcam) (1:1,000), RIP3 (rabbit poly-
clonal; Abcam) (1:1,000), or actin (rabbit polyclonal; Sigma) (1:5,000).
Detectionwas performedwith horseradish peroxidase (HRP)-conjugated
goat anti-rabbit and anti-mouse immunoglobulins (Dako) and enhanced
chemiluminescence (Amersham Pharmacia). Bands were quantified us-
ing ImageJ 1.32 software (NIH). Fold change from mock-infected or
Stop-infected cell results was calculated and normalized to the corre-
sponding fold change seen with actin.
Caspase activity assays.Cellular caspase activitywasmeasuredusing a
fluorescent caspase 3 or caspase 9 assay (Abcam) according to the manu-
facturer’s instructions. Fluorescence was measured on a Flash Varioskan
(Thermo Scientific).
Flow cytometry. Flow cytometric measurements were performed us-
ing a four-color FACSCalibur flow cytometer (Becton, Dickinson).
Forward- and side-scatter light was used to identify cell populations by
size and granularity. In all experiments, 10,000 events were captured and
analyzed with FlowJo software version 9.3.2 (Tree Star, Inc.).
Detection of apoptosis. To detect loss of m, at the required time
points, cells were stained with 10 M 5,5=,6,6=-tetrachloro-1,1=,3,3= tet-
raethylbenzimidazolocarbocyanine iodide (JC-1; Sigma-Aldrich) and an-
alyzed by flow cytometry. Loss of m was demonstrated by a loss of
fluorescence on the FL-2 channel as previously described (45). Nuclear
fragmentation was detected by the use of 4=6=-diamidino-2-phenylindole
(DAPI; Molecular Probes) staining as described previously (21).
LDH assay. The release of lactate dehydrogenase was measured using
a Cytotox 96 cell viability kit (Promega) according to the instructions of
the manufacturer.
Statistics. Results are presented as means and standard errors of the
means, with the number of individual donors used in each data set shown
as the “n” value.Differences between groups of treatmentswere calculated
by analysis of variance (ANOVA) (Bonferroni’s posttest), using Graph-
Pad Prism 5 (GraphPad Software, Inc.). Significance was defined as P 
0.05.
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